Amazon could make James Bond into a 'Marvel-style multiverse'
With Amazon's acquisition of MGM and the recent buyout of EON Productions, the once tightly controlled cinematic legacy of 007 is poised for an unprecedented expansion.
As befits a Bond film, there is a ticking clock counting down.
Not to an explosion, but perhaps something equally impactful: In 10 years Ian Fleming's superspy enters the public domain — so anyone will be able to make their own (legal) James Bond project.
So get ready for Amazon to unleash a deluge of Bond-related content across every conceivable medium.
This would a dramatic departure from the stewardship of EON Productions, which famously protected the franchise's exclusivity, producing a carefully curated series of 25 films over six decades.
Amazon, by contrast, is expected to be (surprise, surprise) aggressive in the marketplace.
With sole ownership of the franchise, the tech giant is likely to pursue a 'scorched earth' strategy: flooding the market with films, television shows, and spin-offs to cement its dominance and discourage competition once Fleming's works become public property.
The end of EON's era
For decades, EON Productions, led by Barbara Broccoli and Michael G. Wilson, maintained an iron grip on Bond's cinematic legacy.
Their deliberate approach sought to preserve Bond's prestige, releasing films only when the story and casting were deemed perfect.
This cautious strategy created a sense of occasion with every new Bond instalment, and protected the brand from oversaturation.
However, Amazon's corporate ethos differs sharply. With a business model that thrives on high churn of content and continuous engagement, the company is unlikely to adhere to EON's patient, film-centric philosophy, instead transforming Bond from a singular film series into a sprawling multimedia multiverse.
Amazon's multiverse of Bond
This approach would mirror the success of franchises like Marvel and DC, where multiple versions of the same character coexist across different films, television shows, and streaming platforms.
For Bond fans, this could mean simultaneous projects featuring multiple actors portraying different versions of the iconic spy.
Imagine a gritty, grounded Bond series on Amazon Prime exploring the origins of the 00 program, while a separate blockbuster film franchise continues the traditional globetrotting adventures.
There could even be alternate universe Bonds — from a futuristic cyber-espionage take to a Cold War period piece faithful to Fleming's original novels.
This multiverse approach would allow Amazon to cater to diverse audiences while maintaining a near-constant flow of Bond-related content.
Such an approach also serves a strategic purpose. Once James Bond enters the public domain competitors could theoretically develop their own adaptations of Bond's original adventures. However, anything derived from the films or original characters not present in Fleming's novels — such as the iconic Aston Martin — remains under Amazon's copyright.
By flooding the market with an array of distinctive Bond properties, Amazon would make it difficult for competitors to carve out their own space.
A future of endless Bonds?
With no legal restrictions preventing multiple Bonds at once, Amazon could leverage the franchise in several innovative ways:
1. Television spin-offs: High-budget Bond TV series could delve into backstories of fan-favourite characters like M, Q, or Felix Leiter, or explore the intricacies of MI6.
2. Competing bonds: Different Bonds providing fresh interpretations, while allowing global audiences to engage with the version of Bond that resonates most with them.
3. Event crossovers: In a move echoing comic-book multiverses, Amazon could stage crossover events, bringing different Bonds together on-screen.
And if they experiment with the use of AI, fans could finally see Sean Connery's suave Bond face off against Daniel Craig's brooding agent — or their modern equivalents.
4. Animated series: Animated adaptations could bring Fleming's novels to life for younger audiences. Maybe even a tween or teen Bond?
Risk vs. reward
This approach is not without risks. Overexposure could dilute the Bond brand's mystique, transforming what was once an eagerly anticipated cinematic event into just another streaming option. Additionally, Amazon faces the challenge of maintaining Bond's core identity while updating the character across many iterations.
Historically, the Bond franchise has thrived by evolving slowly. Too many Bond and Bond-adjacent projects could undermine the franchise's carefully crafted image and alienate long-time fans.
Yet the rewards are potentially enormous. Amazon has already demonstrated its willingness to invest heavily in blockbuster properties, as evidenced by its billion-dollar Lord of the Rings series. By transforming Bond into a myriad of Bonds, Amazon is both protecting a lucrative asset and reinventing 007 for a whole new generation.
Dr Darren Paul Fisher is the Head of Film, Screen and Creative Media at Bond University. An award-winning screenwriter, producer and director, Darren's first book ' Film as Argument ' will be released later this year.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Daily Telegraph
3 hours ago
- Daily Telegraph
Prince Harry to owe more than $1.3 million to British taxpayers over failed legal battle
Digital Reporter Reilly Sullivan claims British taxpayers are set to be owed over $1.3 million in costs related to Prince Harry's failed legal battle with the British Home Office. 'When Harry and Meghan left royal duties, they were no longer entitled to taxpayer-funded Met police officers,' Mr Sullivan told Sky News Digital Presenter Gabriella Power. 'This has really been an ongoing court battle for over four years. 'He's lost multiple times on appeals. 'He will be expected to likely reimburse the home office and therefore the taxpayer this money. 'If he does repay the $1.3 million on top of his own legal fees, it's estimated that he spent in the ballpark of about $5 million just on this legal battle. 'It's not a good look. 'It's the legal system … that really have better things to do with their time than hear Harry's grievance in his $20 million mansion, I think they're sick of it.'

ABC News
3 hours ago
- ABC News
UK medicine regulator warns that women taking Mounjaro, Ozempic need to use effective contraception
Women in the UK have been urged to use effective contraception if they are using weight loss drugs after dozens of reports of unintentional pregnancies from people taking the medication. The Medicines and Healthcare products Regulatory Agency (MHRA) warning said women taking popular "skinny jabs" like Ozempic, Mounjaro and Wegovy should "use a barrier form of contraception and do not rely on oral contraception." The warning comes after the agency received 40 reports relating to unintended pregnancies while using such weight loss drugs. Ying Cheong, a consultant in reproductive medicine at the University of Southampton, called the MHRA's advice "both timely and necessary". "Gastrointestinal side-effects such as vomiting and diarrhoea can impair oral contraceptive absorption, increasing the risk of unintended pregnancy," she said. The warning from the MHRA urged women to use "effective contraception while taking these medicines and, in some cases, for up to two months between stopping the medicine and trying to get pregnant." It also made clear that these drugs "must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding." "Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible… because there is not enough safety data to know whether taking the medicine could cause harm to the baby," it added. Dr Alison Cave, MHRA Chief Safety Officer said "skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments." Rebecca Reynolds, a professor of metabolic medicine at the University of Edinburgh, said there was "hardly any available data from human studies" to know if the weight loss drugs were safe in pregnancy. "The data from animal studies suggests the potential for harm with low birth-weight and skeletal abnormalities, though more evidence is needed to assess if there are risks of taking these drugs in humans," she added. The MHRA also warned about the impact of another weight-loss and diabetes injection, Mounjaro, on the effectiveness of oral contraception for people who are overweight. "Those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception," it said. The MHRA also added a reminder to people that these medicines "should not be bought from unregulated sellers such as beauty salons or via social media", or taken without a a prescription from a doctor. "Not only does this expose people wanting to lose weight to serious health risks, it is also against the law to sell these medicines in this way," the statement said. ABC/AFP

ABC News
3 hours ago
- ABC News
Nightlife News Breakdown: Thursday 5th June 2025
1h ago 1 hours ago Thu 5 Jun 2025 at 12:00pm Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume. Play Duration: 21 minutes 4 seconds 21 m